Charlotte C van Ruiten

3PUBLICATIONS
5CO-AUTHORS
Food properties (incl. characteristics and health benefits)Molecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (3)

|May 02, 2022
Combination therapy with exenatide decreases the dapagliflozin-induced changes in brain responses to anticipation and consumption of palatable food in patients with type 2 diabetes: A randomized controlled trial.

Charlotte C van Ruiten, Dick J Veltman, Madelief Wijdeveld

|Feb 08, 2022
Effects of Dapagliflozin and Combination Therapy With Exenatide on Food-Cue Induced Brain Activation in Patients With Type 2 Diabetes.

Charlotte C van Ruiten, Dick J Veltman, Anouk Schrantee

|Apr 28, 2021
Effect of exenatide twice daily and dapagliflozin, alone and in combination, on markers of kidney function in obese patients with type 2 diabetes: A prespecified secondary analysis of a randomized controlled clinical trial.

Charlotte C van Ruiten, Annemarie B van der Aart-van der Beek, Richard G IJzerman

Pageof 1

Frequent Collaborators

3 joint publications

Max Nieuwdorp

2 joint publications

Richard G IJzerman

1 joint publications

Annemarie B van der Aart-van der Beek

1 joint publications

Daniël H van Raalte